1,743
Participants
Start Date
May 31, 2015
Primary Completion Date
April 7, 2017
Study Completion Date
April 7, 2017
Marketed antagonists
Medication for each patient is determined by the physician based on the patient's individual clinical profile and in accordance with the approved indication and label of the prescribed drug
Teva Investigational Site 1011, Dubrovnik
Teva Investigational Site 1001, Karlovac
Teva Investigational Site 1007, Karlovac
Teva Investigational Site 1015, Metković
Teva Investigational Site 1014, Pula
Teva Investigational Site 1012, Rijeka
Teva Investigational Site 1005, Samobor
Teva Investigational Site 1004, Sisak
Teva Investigational Site 1013, Varaždin
Teva Investigational Site 1006, Zadar
Teva Investigational Site 1002, Zagreb
Teva Investigational Site 1003, Zagreb
Teva Investigational Site 1008, Zagreb
Teva Investigational Site 201, Aalborg
Teva Investigational Site 202, Aarhus
Teva Investigational Site 207, Copenhagen
Teva Investigational Site 204, Hvidovre
Teva Investigational Site 205, Kolding
Teva Investigational Site 203, Næstved
Teva Investigational Site 206, Roskilde
Teva Investigational Site 905, Enniscorthy
Teva Investigational Site 904, Lifford
Teva Investigational Site 903, Mallow
Teva Investigational Site 901, Sligo
Teva Investigational Site 906, Tramore
Teva Investigational Site 902, Youghal
Teva Investigational Site 513, Ancona
Teva Investigational Site 31, Bari
Teva Investigational Site 512, Brescia
Teva Investigational Site 502, Brindisi
Teva Investigational Site 514, Catania
Teva Investigational Site 9, Chieti
Teva Investigational Site 22, Florence
Teva Investigational Site 505, Foggia
Teva Investigational Site 20, Genova
Teva Investigational Site 30, Lecco
Teva Investigational Site 509, Legnago
Teva Investigational Site 3, Modena
Teva Investigational Site 11, Napoli
Teva Investigational Site 8, Napoli
Teva Investigational Site 14, Orbassano
Teva Investigational Site 508, Palermo
Teva Investigational Site 516, Parma
Teva Investigational Site 501, Pavia
Teva Investigational Site 10, Perugia
Teva Investigational Site 18, Pietra Ligure
Teva Investigational Site 506, Pisa
Teva Investigational Site 510, Pordenone
Teva Investigational Site 503, Roma
Teva Investigational Site 21, Sassari
Teva Investigational Site 24, Scafati
Teva Investigational Site 515, Sesto San Giovanni
Teva Investigational Site 507, Siena
Teva Investigational Site 4, Torino
Teva Investigational Site 511, Verona
Teva Investigational Site 606, Alkmaar
Teva Investigational Site 604, Grubbenvorst
Teva Investigational Site 601, Harderwijk
Teva Investigational Site 602, Helmond
Teva Investigational Site 607, Hoofddorp
Teva Investigational Site 603, Hoorn
Teva Investigational Site 605, Rotterdam
Teva Investigational Site 302, Hamar
Teva Investigational Site 303, Holter
Teva Investigational Site 301, Oslo
Teva Investigational Site 304, Oslo
Teva Investigational Site 702, Aveiro
Teva Investigational Site 707, Barcelos
Teva Investigational Site 706, Braga
Teva Investigational Site 701, Covilha
Teva Investigational Site 703, Guimarães
Teva Investigational Site 705, Porto
Teva Investigational Site 704, Vila Nova de Gaia
Teva Investigational Site 119, A Coruña
Teva Investigational Site ES044, A Coruña
Teva Investigational Site 113, Alcorcón
Teva Investigational Site ES048, Alcorcón
Teva Investigational Site 101, Barcelona
Teva Investigational Site 102, Barcelona
Teva Investigational Site 132, Barcelona
Teva Investigational Site 133, Cáceres
Teva Investigational Site 114, Córdoba
Teva Investigational Site 111, Jaén
Teva Investigational Site 105, Laredo
Teva Investigational Site 120, Lugo
Teva Investigational Site 109, Madrid
Teva Investigational Site 110, Madrid
Teva Investigational Site 124, Madrid
Teva Investigational Site 126, Madrid
Teva Investigational Site 134, Madrid
Teva Investigational Site 136, Madrid
Teva Investigational Site 135, Manacor
Teva Investigational Site 108, Málaga
Teva Investigational Site 118, Málaga
Teva Investigational Site 123, Málaga
Teva Investigational Site ES049, Málaga
Teva Investigational Site 128, Murcia
Teva Investigational Site 103, Oviedo
Teva Investigational Site 107, Pamplona
Teva Investigational Site 130, Ponferrada
Teva Investigational Site 131, Pontevedra
Teva Investigational Site 139, Santa Cruz de Tenerife
Teva Investigational Site 117, Santander
Teva Investigational Site 106, Santiago de Compostela
Teva Investigational Site 112, Seville
Teva Investigational Site 122, Seville
Teva Investigational Site 125, Seville
Teva Investigational Site ES046, Seville
Teva Investigational Site 129, Terrassa
Teva Investigational Site 140, Teruel
Teva Investigational Site 104, Valencia
Teva Investigational Site 115, Valencia
Teva Investigational Site 116, Valencia
Teva Investigational Site 127, Valencia
Teva Investigational Site 121, Vic
Teva Investigational Site 138, Zaragoza
Teva Investigational Site 401, Lund
Teva Investigational Site 804, Atherstone
Teva Investigational Site 803, Beccles
Teva Investigational Site 813, Belfast
Teva Investigational Site 816, Birkenhead
Teva Investigational Site 815, Bolton
Teva Investigational Site 812, Bridgwater
Teva Investigational Site 807, Chippenham
Teva Investigational Site 817, Doncaster
Teva Investigational Site 811, Hinckley
Teva Investigational Site 801, Hitchin
Teva Investigational Site 821, Nantwich
Teva Investigational Site 824, Norwich
Teva Investigational Site 806, Portsmouth
Teva Investigational Site 808, Royal Leamington Spa
Teva Investigational Site 820, Sandbach
Teva Investigational Site 805, Thaxted
Teva Investigational Site 818, Thornton-Cleveleys
Teva Investigational Site 819, Tollerton
Teva Investigational Site 809, Trowbridge
Teva Investigational Site 802, Watford
Teva Investigational Site 822, Wells-next-the-Sea
Teva Investigational Site 810, Winchester
Teva Investigational Site 814, Wolverhampton
Teva Investigational Site 823, Wymondham
Teva Pharmaceuticals Europe
INDUSTRY